Bayesian Capital Management »

Tg Therapeutics shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 116k 17.08
2023-06-30 $1.1M 46k 24.84
2022-12-31 $268k 23k 11.83
2022-09-30 $164k 28k 5.94
2022-06-30 $92k 22k 4.24